NewsBenzinga에제너스, 간 전이 없는 MSS, mCRC 환자 대상 보텐실리맙과 발스틸리맙 병용 요법을 평가한 1b상 C-800-01 임상시험의 장기 생존자 분석 결과 발표 에제너스, 간 전이 없는 MSS, mCRC 환자 대상 보텐실리맙과 발스틸리맙 병용 요법을 평가한 1b상 C-800-01 임상시험의 장기 생존자 분석 결과 발표 Benzinga 2026.11.06 14:04 (GMT+0) Open on Benzinga Other news Nvidia Director Reportedly Warns of ‘Irreplaceable Talent’ Loss: Board Urged to Bring Back Jensen Huang as NVDA Stock Slips Elon Musk’s Cybercab Ambitions Get a $3.3 Billion Boost — Tesla Plans 1 Million Units a Year at Berlin Factory NVIDIA Expands Vera CPU Racks for Scientific Computing Are Wall Street Analysts Predicting Lowe's Stock Will Climb or Sink? A whale accumulates 238,400 LINK from Binance in two days, worth about $2.2 million Google Warns ‘Era of Autonomous Attacks Has Arrived’ as United Airlines, JPMorgan Chase and Microsoft Grapple With Outages
Nvidia Director Reportedly Warns of ‘Irreplaceable Talent’ Loss: Board Urged to Bring Back Jensen Huang as NVDA Stock Slips
Elon Musk’s Cybercab Ambitions Get a $3.3 Billion Boost — Tesla Plans 1 Million Units a Year at Berlin Factory
Google Warns ‘Era of Autonomous Attacks Has Arrived’ as United Airlines, JPMorgan Chase and Microsoft Grapple With Outages